Cite
MLA Citation
Dean A Fennell et al.. “Abemaciclib in patients with p16ink4A-deficient mesothelioma (MiST2): a single-arm, open-label, phase 2 trial.” Lancet oncology, vol. 23, no. 3, 2022, pp. 374–381. http://access.bl.uk/ark:/81055/vdc_100152307969.0x000018